InsidersTradesSigma
Follow the SSM stock price and the full directors' dealings record of the company, a listed equity based in Australia. Shares are quoted on the AU market, under the supervision of ASX. Operating in the Health Care sector, SSM has logged 7 reports. Market capitalisation: €1.5bn. The latest transaction was disclosed on 20 May 2026 (Change in Substantial Holding). Among the most active insiders: 2. Changes in relevant interests. All data is free.
7
Insider Decl.
n/a
Thresholds
€6,041
1 ops.
Buy Volume
n/a
n/a
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 7,666 of 29,062 companies
63.3
score / 100
Value59
Quality68
FCF yld5.4%
Earn yld3.8%
EV/EBITDA11.5x
ROE11%
Gross mgn95%
Net mgn2.4%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 20 May 2026
Declarations7 total
ShareASXASX:2924-03092082-3A693682
ShareASXASX:2924-03091677-3A693598
ShareASXASX:2924-03089409-3A693177
ShareASXASX:2924-03087388-3A692810
ShareASXASX:2924-03086846-3A692729
ShareASXASX:2924-03086795-3A692718
5,000 shares@ A$1.980.0005% mcap100.0% of flowShareASXASX:2924-03082246-3A691936
7 of 7 declarations
关于 SSM
SSM 是一家在 XASX 市场上市的医疗保健和制药领域的公司。